Steroid and xenobiotic receptor (SXR) is a key system for the acquisition of cisplatin resistance in endometrial cancer cells

Journal of International Medical Research

Volumn 31, Issue 2, 2003, Pages 59-68

  Takami, N ^a   Sakamoto, H ^a   Yamamoto, T ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Chemotherapy; Cisplan; Drug resistance; Endometrial cancer; Steroid and xenobiotic (SXR)

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CISPLATIN; DEXAMETHASONE; GLUCOCORTICOID; MIFEPRISTONE; PACLITAXEL; PHENOBARBITAL; PREGNENOLONE DERIVATIVE; RIFAMPICIN; STEROID RECEPTOR; UNCLASSIFIED DRUG; XENOBIOTIC AGENT; XENOBIOTIC RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CELL CLONE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; DRUG RESISTANCE; ENDOMETRIUM CANCER; ENDOMETRIUM CELL; FEMALE; MOUSE; NONHUMAN; PHENOTYPE; SCID MOUSE;

EID: 0038029586     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000303100201     Document Type: Article

References (18)

1. Vermorken JB, Hoekman K: Chemotherapy for gynecologic malignancies. Curr Opin Oncol 1995; 7: 457-465.
2. Ozols RF, Vermorken JB: Chemotherapy of advanced ovarian cancer: current status and future directions. Semin Oncol 1997; 24 (Suppl 2): 1-9.
3. Pierga JY, Dieras V, Paraiso D, Pouillart P: Chemotherapy of metastatic endometrial carcinoma. Review of the literature. Bull Cancer 1995; 82: 1005-1018.
4. Harries M, Gore M: Part I: Chemotherapy for epithelial ovarian cancer-treatment at first diagnosis. Lancet Oncol 2002; 3: 529-536.
5. Harries M, Gore M: Part II: Chemotherapy for epithelial ovarian cancer-treatment of recurrent disease. Lancet Oncol 2002; 3: 537-545.
6. Nakayama Y, Sakamoto H, Yamamoto T: Establishment and characterization of CDDP resistant sub-clone from Ishikawa endometrial cells. Hum Cells 2003 (in press).
7. Falkner KC, Pinaire JA, Xiao GH, Geoghegan TE, Prough RA: Regulation of the rat glutathione S-transferase A2 gene by glucocorticoids: involvement of both the glucocorticoid and pregnane X receptors. Mol Pharmacol 2001; 60: 611-619.
8. Nisida M, Kasahara K, Kaneko M, Iwasaki H, Hayashi K: Establishment of a new human endometrial adenocarcinoma cell line, Ishikawa cells, containing estrogen and progesterone receptors (in Japanese). Nippon Sanka Fujinka Gakkai Zasshi 1985; 37: 1103-1111.
9. T Kato, M Sakai, M Muramatsu: Structure and expression of a human class pi glutathione S-transferase messenger RNA. Cancer Res 1987; 47: 5626-5630.
10. Kliewer SA, Moore JT, Wade L, Staudinger JL, Watson MA, Jones SA, et al: An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway. Cell 1998; 92: 73-82.
11. Lehmann JM, McKee DD, Watson MA, Willson TM, Moore JT, Kliewer SA: The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. J Clin Invest 1998; 102: 1016-1023.
12. Murray M: Mechanisms and significance of inhibitory drug interactions involving cytochrome P450 enzymes. Int J Mol Med 1999; 3: 227-238.
13. Kast HR, Goodwin B, Tarr PT, Jones SA, Anisfeld AM, Stoltz CM, et al: Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor. J Biol Chem 2002; 277: 2908-2915.
14. Goto S, Iida T, Cho S, Oka M, Kohno S, Kondo T. Overexpression of glutathione S-transferase pi enhances the adduct formation of cisplatin with glutathione in human cancer cells. Free Radic Res 1999; 31: 549-558.
15. Goto S, Ihara Y, Urata Y, Izumi S, Abe K, Koji T, et al: Doxorubicin-induced DNA intercalation and scavenging by nuclear glutathione S-transferase pi. FASEB J 2001; J15: 2702-2714.
16. Mayr D, Pannekamp U, Baretton GB, Gropp M, Meier W, Flens MJ, et al: Immunohistochemical analysis of drug resistance-associated proteins in ovarian carcinomas. Pathol Res Pract 2000; 196: 469-475.
17. Barnette KG, Sarkar MA, Glover DD, Li P, Boyd C, Lalka D: Glutathione S-transferase in human endometrium: quantitation and interindividual variability in isoform content. Gynecol Obstet Invest 1999; 47: 114-119.
18. Jeronimo C, Varzim G, Henrique R, Oliveira J, Bento MJ, Silva C, et al: I105V polymorphism and promoter methylation of the GSTP1 gene in prostate adenocarcinoma. Cancer Epidemiol Biomarkers Prev 2002; 11: 445-450.